title: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
abstract: Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.
authors.affiliation: University of Cambridge School of Clinical Medicine, Cambridge, UK. jec1001@hermes.cam.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Compston
authors.forename: C
authors.initials: C
authors.lastname: Bowring
authors.forename: A
authors.initials: A
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Davies
authors.forename: R
authors.initials: R
authors.lastname: Francis
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
authors.forename: D
authors.initials: D
authors.lastname: Marsh
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: D M
authors.initials: DM
authors.lastname: Reid
authors.forename: P
authors.initials: P
authors.lastname: Selby
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002136:Calcium, Dietary / Q000627:therapeutic use*; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy*; D018570:Risk Assessment; D006113:United Kingdom; D014807:Vitamin D / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D
keywords: FRAX; Fracture; Guideline; Osteoporosis